Dopamine receptors: Molecular biology, biochemistry and behavioural aspects

https://doi.org/10.1016/0163-7258(94)90041-8Get rights and content

Abstract

The description of new dopamine (DA) receptor subtypes, D1-(D1 and D5) and D2-like (D2A, D2B, D3, D4), has given an impetus to DA research. While selective agonists and antagonists are not generally available yet, the receptor distribution in the brain suggests that they could be new targets for drug development. Binding characteristics and second messenger coupling has been explored in cell lines expressing the new cloned receptors. The absence of selective ligands has meant that in vivo studies have lagged behind. However, progress has been made in understanding the function of DA-containing discrete brain nuclei and the functional consequence of the DA's interaction with other neurotransmitters. This review explores some of the latest advances in these various areas.

References (796)

  • J. Arnt et al.

    Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions

    Eur. J. Pharmac.

    (1984)
  • J. Arnt et al.

    GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists

    Life Sci.

    (1979)
  • J. Arnt et al.

    Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behavior in rats

    Eur. J. Pharmac.

    (1987)
  • J. Arnt et al.

    Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats

    Eur. J. Pharmac.

    (1988)
  • C.R. Ashby et al.

    Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons

    Eur. J. Pharmac.

    (1990)
  • J. Axelrod et al.

    Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers

    Trends Neurosci.

    (1988)
  • P. Barone et al.

    Dopaminergic functions and motor function: characterization of D-1 and D-2 dopamine receptor interactions

    Eur. J. Pharmac.

    (1986)
  • R.A. Barraco et al.

    Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine

    Brain Res.

    (1983)
  • G. Battaglia et al.

    D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum

    Neurosci. Lett.

    (1985)
  • S. Benloucif et al.

    Facilitation of dopamine release in vivo by serotonin agonists: studies with microdianalysis

    Eur. J. Pharmac.

    (1991)
  • G.M. Bokoch et al.

    Identification of the predominant substrate for ADP-ribosylation by islet activating protein

    J. biol. Chem.

    (1983)
  • R.C. Boldry et al.

    The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-d-aspartate into the nucleus accumbens

    Neuropharmacology

    (1988)
  • R.C. Boldry et al.

    The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA

    Brain Res.

    (1991)
  • R.C. Boldry et al.

    Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions

    Neurosci. Lett.

    (1992)
  • M.L. Bouthenet et al.

    A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]-iodosulpride

    Neuroscience

    (1987)
  • M.L. Bouthenet et al.

    Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA

    Brain Res.

    (1991)
  • P.U. Bracs et al.

    Dopamine applied into the nucleus accumbens and discriminative avoidance in rats

    Pharmac. Biochem. Behav.

    (1984)
  • A.R. Braun et al.

    Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

    Eur. J. Pharmac.

    (1986)
  • M.P. Brazell et al.

    Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen

    Neuropharmacology

    (1990)
  • A. Bruinink et al.

    Ontogeny of diurnal rhythms of central dopamine, serotonin and spirodecanone binding sites and of motor activity in the rat

    Life Sci.

    (1983)
  • D.R. Bull et al.

    Characterization of dopamine autoreceptors in the amygdala: a fast cyclic voltammetric study in vitro

    Neurosci. Letts

    (1991)
  • M. Buonamici et al.

    D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions

    Eur. J. Pharmac.

    (1986)
  • D.L. Cameron et al.

    Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity

    Neurosci. Lett.

    (1988)
  • R. Camsonne

    Dopamine receptors in brain and periphery: some prospects

    Neurochem. Int.

    (1987)
  • E. Carboni et al.

    SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia

    Eur. J. Pharmac.

    (1986)
  • J.H. Carlson et al.

    Neurophysiological evidence that D1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists

    Eur. J. Pharmac.

    (1986)
  • J.H. Carlson et al.

    Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study

    Brain Res.

    (1987)
  • J.H. Carlson et al.

    Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation

    Eur. J. Pharmac.

    (1988)
  • M. Carlsson et al.

    The non-competitive NMDA antagonists MK 801 and PCP, as well as the competitive antagonists SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice

    Life Sci.

    (1990)
  • M. Carlsson et al.

    Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration disclose the locomotor stimulatory potential of other transmitter systems

    Pharmac. Biochem. Behav.

    (1990)
  • D.P. Carrozza et al.

    Partial characterization of kainic acid-induced striatal dopamine release using in vivo microdialysis

    Brain Res.

    (1991)
  • D.P. Carrozza et al.

    In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-d-aspartate-evoked striatal dopamine release and effects of antagonists

    Brain Res.

    (1992)
  • M.E. Castelló et al.

    Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats

    Pharmac. Biochem. Behav.

    (1992)
  • G.K. Aghajanian et al.

    Dopamine 'autoreceptorsrs: pharmacological characterization by microiontophoretic single cell recording studies

    Naunyn-Schmiedeberg's Arch. Pharmac.

    (1977)
  • S. Ahlenius

    Effects of low and high doses of l-DOPA on the tetrabenazine or α-methyltyrosine-induced suppression of the behaviour in a successive discrimination task

    Psychopharmacologia (Berl.)

    (1974)
  • S. Ahlenius

    Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors

    Naunyn-Schmiedeberg's Arch. Pharmac.

    (1992)
  • A. Albanese

    Extrapyramidal system, motor ganglia and movement disorders

    Rev. Neurosci.

    (1990)
  • C.A. Altar et al.

    Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography

    Science

    (1985)
  • N.-E. Andén

    Regulation of monoamine synthesis and utilization by receptors

  • N.-E. Andén et al.

    Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity

    Psychopharmacologia (Berl.)

    (1974)
  • Cited by (0)

    View full text